Timelo Investment Management’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-185,098
Closed -$1.6M 27
2023
Q2
$1.6M Sell
185,098
-294,000
-61% -$2.63M 1.1% 16
2023
Q1
$4.33M Buy
479,098
+74,372
+18% +$649K 4.25% 8
2022
Q4
$3.18M Buy
404,726
+500
+0.1% +$3.51K 2.35% 11
2022
Q3
$2.49M Sell
404,226
-522,575
-56% -$3.15M 2.87% 13
2022
Q2
$4.91M Buy
926,801
+487,461
+111% +$2.95M 4.47% 5
2022
Q1
$2.88M Buy
439,340
+203,442
+86% +$1.81M 2.09% 9
2021
Q4
$3.87M Buy
+235,898
New +$4.92M 2.07% 12

Other funds holding ZYME

Timelo Investment Management's ZYME Position: Q3 2023 in Review

Timelo Investment Management sold out of Zymeworks (ZYME) in Q3 2023, closing a stake of 185,098 shares — an estimated $1.6M sold.

Timelo Investment Management first reported a position in ZYME in Q4 2021 and held it in 7 quarters. The position peaked at $4.91M in Q2 2022. 139 funds tracked by Wall St. Rank hold ZYME as of Q3 2023.

  • Timelo Investment Management reported no remaining Zymeworks position as of Q3 2023 after selling out during the quarter.
  • Timelo Investment Management sold 185,098 Zymeworks shares in Q3 2023, an estimated $1.6M.
  • Timelo Investment Management first reported a position in Zymeworks in Q4 2021 and held it in 7 quarters.
  • Timelo Investment Management's Zymeworks position peaked at $4.91M in Q2 2022.
  • 139 funds tracked by Wall St. Rank held Zymeworks as of Q3 2023.

Based on Timelo Investment Management's 13F filing for Q3 2023, filed 13 Nov 2023.